Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Pot Stocks Are on a Big Election High as Markets Jump

By Dan Caplinger - Jan 6, 2021 at 12:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Predicting market moves proves difficult again, but cannabis investors have high hopes for the future.

Wednesday morning brought a return to the bullish market environment that we saw throughout much of 2020. Many had predicted that stocks would sell off if it appeared that the Georgia runoff elections for the U.S. Senate would lead razor-thin Democratic control of Congress. However, after an initial drop, major benchmarks pushed substantially higher by midmorning. Just before 11 a.m. EST, the Dow Jones Industrial Average ( ^DJI -0.17% ) was up 476 points to 30,868. The S&P 500 ( ^GSPC -0.84% ) gained 42 points to 3,769, and the Nasdaq Composite ( ^IXIC 0.00% ) picked up 28 points to 12,847.

One unabashed winner in the aftermath of the Georgia elections was the cannabis stock sector. Even though marijuana companies have been able to find ways to operate in the state-by-state patchwork of legality they've found, many cannabis investors have hoped for a more unified approach to pot legalization that's more clearly consistent with the concept of federalism and the Supremacy Clause of the U.S. Constitution. The odds of such an outcome may just have improved considerably.

U.S. Capitol building as seen from street level on a clear, windy day.

Image source: Getty Images.

Big gains for pot stocks

Stocks across the cannabis sector had extremely strong gains. Tilray ( TLRY ) and Canopy Growth ( CGC -3.57% ) were among the biggest winners, with rises of 16%. Aurora Cannabis ( ACB -5.21% ) saw an 11% jump, and Cronos Group ( CRON -5.46% ) and Aphria ( APHA ) managed to post increases of 13% and 11%, respectively.

The argument for these gains is simple: Marijuana investors want pot legalized in the U.S. at the national level.

It's not so much that investors expect that cannabis would suddenly become available to everyone across the country. Even if a federal law were to decriminalize marijuana, it wouldn't necessarily follow that the federal government would take the additional step of exercising supremacy and saying that states would no longer be able to declare pot ownership a crime. Indeed, there would likely be substantial opposition to that infringement on states' rights.

However, there'd be massive benefits to making cannabis legal under federal law. The most important is that U.S.-based pot operators would be able to start acting like normal businesses. Currently, many financial institutions avoid working with local dispensaries due to the uncertain status of their businesses in dealing with federally declared controlled substances. Legalization would suddenly make regular banking relationships possible, taking away the cash-heavy alternatives that pot shops across the country have largely had to resort to in order to stay in business.

Another type of move for pot stocks

The other big impact of federal legalization would be to make more marijuana stocks accessible to investors. Currently, major stock exchanges like the NYSE and Nasdaq haven't allowed U.S.-based cannabis companies to list their shares because of their businesses being illegal at the federal level. That's led to the difficult situation in which legal Canadian pot stocks get to list on U.S. exchanges, while U.S. pot companies have to settle for over-the-counter trading.

Trading over the counter has several downsides. It can be harder to trade stocks that aren't on major exchanges, as there are fewer market makers helping to keep trading orderly and provide liquidity. More importantly, brokers like Robinhood don't even allow trading in over-the-counter securities, and even those brokers that do sometimes charge additional fees or introduce other hurdles that NYSE- and Nasdaq-listed stocks get to avoid.

If federal cannabis legalization were to occur, that would likely change. U.S. pot stocks currently relegated to over-the-counter trading would scurry to file for major exchange listings. That would dramatically increase availability of stocks, enabling companies like Curaleaf Holdings ( CURLF -0.65% ), Green Thumb ( GTBIF -1.20% ), and Trulieve ( TCNNF 1.03% ) to find their way into more investors' portfolios. It's no surprise to see shares of those companies up 8% to 10% today as well.

Keep your eyes on Washington

Final results of the Georgia elections aren't yet in, and even if control of the Senate does change hands, there will still be huge political battles with no margin of error. Nevertheless, investors generally feel comfortable that they'll be able to deal with whatever comes -- and pot stock shareholders will eagerly await what happens with marijuana legislation in 2021.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$9.23 (-0.65%) $0.06
Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$34,580.08 (-0.17%) $-59.71
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
$4,538.43 (-0.84%) $-38.67
NASDAQ Composite Index (Price Return) Stock Quote
NASDAQ Composite Index (Price Return)
$15,381.32 (0.00%) $0.00
Aurora Cannabis Stock Quote
Aurora Cannabis
$5.82 (-5.21%) $0.32
Canopy Growth Stock Quote
Canopy Growth
$9.99 (-3.57%) $0.37
Cronos Group Stock Quote
Cronos Group
$4.16 (-5.46%) $0.24
Tilray Stock Quote
Green Thumb Industries Stock Quote
Green Thumb Industries
$20.64 (-1.20%) $0.25
Aphria Stock Quote
Trulieve Cannabis Stock Quote
Trulieve Cannabis
$26.45 (1.03%) $0.27

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.